Trial Profile
Efficacy and Safety of Xeomin for the Treatment of Notalgia Paresthetica
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Sep 2014
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Pruritus
- Focus Therapeutic Use
- Sponsors Merz Pharmaceuticals GmbH
- 17 Sep 2014 New trial record